MHC-bound antigens and proteomics for novel target discovery

被引:10
作者
Shoshan, SH [1 ]
Admon, A [1 ]
机构
[1] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel
关键词
autoimmune; cancer; degradome; DRiPs; HLA; immunotherapy; mass spectrometry; MHC; peptidome; proteomics;
D O I
10.1517/14622416.5.7.845
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The MHC molecules present normal as well as disease-related and pathogen-derived peptides to T cells as a way of alerting the immune system of the health status of a cell. Proteomic technologies involving immunoaffinity purification are now extensively used to separate MHC complexes from their peptide cargo, and then the petides are sequenced by tandem mass spectrometry. The identified peptides are tested as vaccine candidates for viral diseases, immunostimulants for treating cancer, and immune-tolerance-inducing agents for autoimmune disorders. One of the challenges in devising novel HLA-peptide-based immunotherapies is to decipher whether a therapeutic window exists between the induction of tumor immunity and the onset of autoimmunity, which can have dangerous sequelae. This review will cover these topics with an overview of the vast possibilities emerging in the field of proteomic analyses of MHC-bound antigens as novel targets for immunotherapy.
引用
收藏
页码:845 / 859
页数:15
相关论文
共 120 条
[1]  
Adida C, 2000, BLOOD, V96, P1921
[2]   Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides [J].
Admon, A ;
Barnea, E ;
Ziv, T .
MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (06) :388-398
[3]   Selective immunointervention in autoimmune diseases: Lessons from multiple sclerosis [J].
Adorini, L .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (03) :219-234
[4]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[5]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[6]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[7]   Human leukocyte antigen class I supertypes influence susceptibility and severity of tuberculosis [J].
Balamurugan, A ;
Sharma, SK ;
Mehra, NK .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) :805-811
[8]  
Barnea E, 2002, EUR J IMMUNOL, V32, P213, DOI 10.1002/1521-4141(200201)32:1<213::AID-IMMU213>3.3.CO
[9]  
2-#
[10]   Improving large-scale proteomics by clustering of mass spectrometry data [J].
Beer, I ;
Barnea, E ;
Ziv, T ;
Admon, A .
PROTEOMICS, 2004, 4 (04) :950-960